When was Sanofi founded?

Sanofi was founded in 1973 and raised its 1st funding round 36 years after it was founded.

Where is Sanofi located?

Sanofi is headquartered in Paris, France. It is registered at 240, ร่มเกล้า, มีนบุรี, เขตมีนบุรี, กรุงเทพมหานคร.

Who is the current CEO of Sanofi?

Paul Hudson and Erik Louwerens s of Sanofi. Erik Louwerens has also founded 2 companies.

How many employees does Sanofi have?

As of Jul 31, 2026, the latest employee count at Sanofi is 93330.

Is Sanofi a funded company?

Sanofi is a funded company, having raised an undisclosed amount across 16 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 06, 2009.

When was the latest funding round of Sanofi?

Sanofi's latest funding was a $***** Post IPO round on Jul 12, 2023, with participation from 1 investor.

Where does Sanofi rank among its competitors?

Sanofi ranks 31st amongst 1989 active competitors, of which 102 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Sanofi?

Sanofi's top competitors include AbbVie, Merck and Gilead. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Sanofi - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of biopharmaceutical products focused on immunology, neurology, oncology, and vaccines. The company researches and develops medicines and vaccines, applying its understanding of the immune system. It focuses on addressing healthcare, environmental, and societal challenges. The company is involved in clinical trials and studies.

Website: www.sanofi.com/en
Social
Email ID: *****@sanofi.com
Phone Number: +33 **********
Registered Address: 240, ร่มเกล้า, มีนบุรี, เขตมีนบุรี, กรุงเทพมหานคร

Key Metrics

Founded Year

1973

Location

Paris, France

Stage

Acquired

Latest Funding Round

Post IPO, Jul 12, 2023, $*****

Investors

Digital Pharma Lab & 13 more

Ranked

31^st among 1989 active competitors

Employee Count

93,330 as on Jul 31, 2026

Investment & Acquisitions

Basis & 75 more

Similar Companies

AbbVie & 2017 more

Exit Details

Acquired by Beximco Pharma (Sep 14, 2021)

View Sanofi's full profile

Sanofi is associated with 8 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Banco Santander, S.a. CIN: 0001121404 , United States, Active		-	-	-
SANOFI WINTHROP INDUSTRIE CIN: 775662257 , France, Deadpooled	Dec 30, 2004	-	-	-
Sanofi A/S CIN: 19064301 , Denmark, Active	Jan 14, 1996	-	-
SARNTI PACKING CO., LTD. CIN: 0105517005925 , Thailand, Active	May 02, 1974	$50M - $100M (As on Dec 31, 2022)	-
SANOFI PASTEUR INDIA PRIVATE LIMITED CIN: U24232MH1996PTC205997 , India, Amalgamated	Jan 05, 1996	₹100 - ₹500 Cr (As on Mar 31, 2020)	-
Sanofi-synthelabo (india) Private Limited CIN: U24230MH2002PTC137682 , India, Amalgamated	Oct 25, 2002	₹500 - ₹1,000 Cr (As on Mar 31, 2020)	-
SANOFI HEALTHCARE INDIA PRIVATE LIMITED CIN: U24110MH1993PTC332584 , India, Active	Mar 10, 1993	₹1,000+ Cr (As on Mar 31, 2025)	3821 (As on Apr 01, 2026)
BIOVERATIV INC. CIN: 1681689 , United States, Active	Aug 03, 2016	$1B+ (As on Dec 31, 2017)	356 (As on Dec 31, 2018)	-

Sanofi got acquired by Beximco Pharma on Sep 14, 2021.

Click here to take a look at Sanofi's acquisition in detail

Sanofi has raised funding over 16 rounds. Its first funding round was on May 06, 2009. Its latest funding round was a Post IPO round on Jul 12, 2023 for $*****. 1 investor participated in its latest round. Sanofi has 14 institutional investors.

Here is the list of recent funding rounds of Sanofi:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 12, 2023	4614354	Post IPO	1183416	4335289	3004714	7962721
Jun 01, 2022	8848603	Grant (prize money)	9424999	2054332	5092013	Europa
Mar 16, 2022	4382269	Post IPO	5246907	7932769	6823546	Blackstone

Access funding benchmarks and valuations. Sign up today!

View details of Sanofi's funding rounds and investors

The founders of Sanofi are Jean Rene Sautier and Yvgeny Chaplinsky. Paul Hudson is the CEO of Sanofi.

Here are the details of Sanofi's key team members:

Jean Rene Sautier: Founder of Sanofi.
Yvgeny Chaplinsky: Founder of Middle-East & Central Asia Generics Business / Director Strategy, Bus. Dev. & Operations of Sanofi.
Paul Hudson: CEO of Sanofi.
Erik Louwerens: Founder, Director of Sanofi and founder of 1 other company.

View details of Sanofi's Founder profiles and Board Members

Sanofi's employee count trend

Sanofi has 93,330 employees as of Jul 26. Here is Sanofi's employee count trend over the years:

Uncover Sanofi's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sanofi include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of Sanofi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	83/100
2nd	Merck 1891, Rahway (United States), Public	Manufacturer of pharmaceutical products	-	Bill & Melinda Gates Foundation, Berkshire Hathaway ... & 11 others	82/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
4th	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	80/100
5th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	77/100
6th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
7th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 17 others	75/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	72/100
9th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 9 others	71/100
10th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 12 others	71/100
31st	Sanofi 1973, Paris (France), Acquired	Developer of biopharmaceutical products focused on immunology, neurology, oncology, and vaccines	-	Digital Pharma Lab, Aisling Capital & 12 others	69/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Sanofi's competitors? Click here to see the top ones

Sanofi has made 47 investments in companies including Basis and Altesa Biosciences. Sanofi has also acquired 29 companies including Dynavax and Vicebio.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 02, 2026	Investments	Basis		Philadelphia (United States)
Feb 13, 2026	Investments	Altesa Biosciences	2020	College Park (United States)
Jan 28, 2026	Investments	Sensorion	2009	Montpellier (France)